Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The Children's Beverage Group (TCBG) -- Ignore unavailable to you. Want to Upgrade?

To: A66TALLguy who wrote (1861)	9/16/1998 10:46:00 AM
From: KSully	Read Replies (2) \| Respond to of 2452

TCBG started trading on 05/30/97 and at a price of $5.75 per share. As indicated in a previous post, the Chicago Tribune on 05/14/97 reported that Savant Biotechnology was changing its name to the Children's Beverage Group. IMO, the name change as reported on 05/14 and the start of trading as indicated on 05/30 strongly suggests that Savant was a pubicly traded concern "prior" to the name change. In addition, and given the time frame of when the name change was reported (05/14) to the date the change took effect (05/30) suggests a majority shareholder. Two reasons of support for the above opinions. The first involves the Chicago Tribune. Why would they report a name change of a private/non-publicly traded concern? Does not make sense to me so I have opinionated that Savant was a publicly traded concern. The second involves the time frame of the name change. A name change was announced and two weeks later, it took effect. Obtaining shareholder approval is at least a 30 day process. As such, I have opinionated that Savant had a majority shareholder of which served to speed up the process. A "reverse merger" can not be ruled out. Right now, however, we have a going concern that changed names and direction. If a reverse merger took place, it was prior to the name change. But if a shell company, than what is there that suggests a stock price of $5.75 per share? To date, I have only uncovered the abstract of the Chicago Tribune article dated 05/14/97 indicating the name change. The article regarding Savant/TCBG might present greater detail/more general information. It should be noted that I have not had the time to check out the Tribune archives to read/obtain the article in its entirety. Savant Biotechnology does not have any SEC filings online. I have looked and others have e-mailed me that they have looked. I have also been unable to date to obtain any trading activity regarding Savant. Historical quotes regarding TCBG go back as far as 05/30/97 and as stated previously, started trading at $5.75 per share In consideration of the fact that there are no audited financials and little to no information regarding TCBG in general, back tracking the roots of TCBG might provide additional information and or insight. I'm very much curious as to what justified a $5.75 stock price. In addition, review the historical quotes regarding TCBG. TCBG was a thinly traded stock. Infact, it did not trade over 50,000 shares until 11/25/97. Did not trade over 100,000 shares until 02/20/98. Did not trade over 1 million shares until 06/19/98. TCBG has been in decline. It was not until April that life was sparked into these shares (ie: New Beverage Release). In regards to trading over 1 million shares in a single session, this took place three times. Once on 06/19, again on 07/08 and 07/09. Trading activity over these periods coincide with the Cliffstar. Sweet Ripe, and Wal-Mart announcements. Prior to such activity and announcements, TCBG hit a low of 7/8 on 03/19/98. It traded as high as 1 15/16 during the period of announcements. TCBG since then has established new lows (brief trades in the 50 cent range) and has since established itself in the 75 cent per share range and waiting news from the Company. TCBG since 03/19/98 has traded 100% higher since the low of 7/8 on that date (1 15/16). Had a steeper spike upward occured, I could see where someone would step in to short the stock (via Canada since one can not short stocks at these levels in the US). There could have been a short interest established when TCBG was trading in the $7 per share range. But honnestly. Wouldn't those shorts have covered their positions by now? The increase in activity could have caught the market makers by surprise. But after these several months, I would suspect that they have made the appropriate adjustments. IMO, TCBG has consolidated in these ranges and it simply waiting for news as to its products. Whether this be samples mailed to investors, BrainForest shipped to Chicagoland, and or product delivered to Wal-Mart. A "SHOW ME THE PRODUCT" situation that once accomplished - will boost investor confidence going foward. All us investors can do is sit and wait. But we do not have to sit on our hands. We have the lead of Savant Biotechnology to research. TCBG started trading at a $5.75 per share stock price. How many shares were outstanding at that time and what assets justified such a stock price? If any?? I would appreciate any and all information that can be supplied and please - do not hesitate to post opinions and thoughts. That is what these message boards are all about. Happy Investing KSully